Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes

By Puig J.M.   Lloveras J.   Fernandez-Crespo P.   Mir M.   Marcas L.I.   Manresa J.M.   Masramon J.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2226-2227

Elsevier

Access to resources Recommend Favorite

Decreased Rejection Episodes in African-American Renal Transplant Recipients Receiving Mycophenolate Mofetil/Tacrolimus Therapy

By Weber M.   Deng S.   Arenas J.   Aradhye S.   Grossman R.   Shaw L.   Naji A.   Barker C.   Brayman K.L.  

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3669-3670

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients

By Esmeraldo R.M.   Donadi M.O.R.C.   Oliveira M.L.   Ponte C.N.   Pinheiro P.M.A.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3007-3008

Elsevier

Access to resources Recommend Favorite

Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients

By Demirbas A.   Tuncer M.   Yavuz A.   Gurkan A.   Kacar S.   Cetinkaya R.   Tekin S.   Akbas S.H.   Akaydin M.   Ersoy F.   Yakupoglu G.  

Transplantation Proceedings, Vol. 36, Iss. 1, 2004-01 ,pp. : 175-177

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil/neoral/steroid vs neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients

By Carmellini M.   Vistoli F.   Bellini R.   Boggi U.   Rindi P.   Rizzo G.   Mosca F.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1162-1164

Elsevier

Access to resources Recommend Favorite